Rhinebeck Bancorp, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Rhinebeck Bancorp, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2.41	2.81	2.82	2.28	2.58	2.83	2.88	3	2.98
Interest expense	3.3	5.32	8.74	8.02	4.29	6.76	22.7
Pre-tax income	6.6	5.37	7.49	7.48	15	8.9	5.61	-10.9	12.7
Income tax	3.6	1.01	1.53	1.56	3.43	1.9	1.22	-2.32	2.64
Net income	3	4.36	5.96	5.92	11.6	7	4.4	-8.62	10
EPS, basic			0.56	0.55	1.07	0.65	0.41	-0.80	0.93
EPS, diluted			0.56	0.55	1.06	0.64	0.40	-0.80	0.92
Shares, basic (weighted)			10.7	10.7	10.8	10.8	10.8	10.8	10.8
Shares, diluted (weighted)			10.7	10.7	11	11	10.9	10.8	11

Balance sheet

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	10.5	50.6	12	93.5	72.1	31.4	22.1	37.5	102
Property, plant and equipment	17	17	18.3	18.8	19.2	18.7	17.6	14.1	13.6
Lease right-of-use assets				6.29	7.84	6.9	6.24	7.31	6.05
Goodwill	1.51	1.41	1.41	1.41	2.24	2.24	2.24	2.24	2.24
Intangible assets	0.33	0.28	0.24	0.2	0.43	0.33	0.25	0.17	0.11
Total assets	742	882	974	1,129	1,281	1,336	1,313	1,256	1,302
Total liabilities	687	823	864	1,012	1,155	1,228	1,200	1,134	1,165
Paid-in capital	0.1	0.1	45.9	46	46.6	47.1	46	45.9	45.7
Retained earnings	61.8	66.2	72.2	78.1	89.6	96.6	100	91.8	102
Other comprehensive income	-6.96	-7.01	-4.1	-3.79	-6.64	-32.2	-29.5	-12.9	-7.93
Shareholders' equity	55	59.3	110	116	126	108	114	122	137
Total equity	55	59.3	110	116	126	108	114	122	137
Total liabilities and equity	742	882	974	1,129	1,281	1,336	1,313	1,256	1,302
Shares outstanding	0	0	11.1	11.3	11.3	11.3	11.1	11.1	11.1

Cash flow statement

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	3	4.36	5.96	5.92	11.6	7	4.4	-8.62	10
Depreciation and amortization				1.38	1.56	1.56	1.4	1.34	1.3
Stock-based compensation				0.22	0.62	0.62	0.4	0.02	0.04
Deferred income tax	1.92	0.1	-0.09	-1.53	1.11	0.01	-0.35	-2.58	1.84
Cash from operations	5.39	8.61	12.1	14.8	7.65	14.8	7.05	8.47	11.7
Capital expenditures	-0.7	-1.15	-2.59	-1.87	-1.77	-1.13	-0.58	-0.79	-0.85
Purchases of investments	-23.7	-3.89	-41.1	-39.2	-245	-30.2		-71.4	-49
Sales and maturities of investments	30.8	2.11	11.9	7	4	14.8	0	75	0
Cash from investing	-24	-104	-132	-74.1	-136	-124	14.7	74.7	21.2
Debt issued		7.87	21.5
Debt repaid				-11.3	-16.8
Stock issued					0.04
Share buybacks									-0.1
Cash from financing	16.1	136	81.4	141	107	68.1	-31	-67.9	31.6
Net change in cash	-2.52	40.1	-38.6	81.5	-21.4	-40.7	-9.26	15.4	64.5
Free cash flow	4.69	7.46	9.52	13	5.88	13.7	6.47	7.68	10.9
Interest paid	3.3	5.14	8.63	8.31	4.61	6.07	22	26.1	22.3
Income taxes paid	1.41	0.63	1.69	3.4	-0.04	1.9	1.5	0.87	0.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $12.83 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Pre-tax margin	417.9%	Pre-tax income / revenue.
Net margin	329.8%	Net income / revenue.
FCF margin	425.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	471.8%	Cash from operations / revenue.
Effective tax rate	21.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	7.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.7%	Net income / average total assets.
Stock-based pay / revenue	3.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	46.6%	Capital expenditures / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-0.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	12.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	11.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y	12.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	10.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	38.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-7.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-4.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	41.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-7.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-3.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	3.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-0.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Liabilities / assets	90.5%	Total liabilities / total assets.
Goodwill and intangibles / assets	0.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$137.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.00x	Revenue / average total assets.
Fixed asset turnover	0.23x	Revenue / average property, plant and equipment.
FCF conversion	128.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	9.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.90	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.27	Revenue / diluted weighted shares.
FCF per share	$1.16	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.29	Cash from operations / diluted weighted shares.
Book value per share	$12.49	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$12.28	Tangible book value / shares outstanding.
Cash per share	$27.24	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$200.6M	Share price x shares outstanding.
Enterprise value	-$104.0M	Market cap + total debt - cash - short-term investments.
P/E	20.3x	Market cap / net income. Only when net income is positive.
P/S	67.1x	Market cap / revenue.
P/B	1.44x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.46x	Market cap / tangible book value, when positive.
P/FCF	15.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	14.2x	Market cap / cash from operations, when positive.
FCF yield	6.3%	Free cash flow / market cap.
Earnings yield	4.9%	Net income / market cap (the inverse of P/E).
PEG	1.58x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Rhinebeck Bancorp, Inc.'s revenue in fiscal 2025?

Rhinebeck Bancorp, Inc. reported revenue of $3.0M for fiscal 2025, 0.6% lower than the year before.

Was Rhinebeck Bancorp, Inc. profitable in fiscal 2025?

Yes. Net income was $10.0M, a net margin of 336.6%.

How much free cash flow did Rhinebeck Bancorp, Inc. generate in fiscal 2025?

Cash from operations of $11.7M minus capital expenditures of $850.0K left free cash flow of $10.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Rhinebeck Bancorp, Inc.